![Minori Rosales](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Minori Rosales
Hoofd Techniek/Wetenschap/O&O bij
SYMBIO PHARMACEUTICALS LIMITED
Profiel
Minori Rosales currently works at SymBio Pharmaceuticals Ltd., as Chief Medical Officer & Vice President from 2026.
Dr. Rosales also formerly worked at MedImmune LLC, as Vice President from 2017 to 2018, MacroGenics, Inc., as Vice President-Clinical Research from 2018 to 2022, Sesen Bio, Inc., as Chief Development Officer from 2022 to 2023, and Compass Therapeutics, Inc., as Senior Vice President & Head-Clinical Development from 2023 to 2025.
Dr. Rosales received her doctorate degree from Yamaguchi University and doctorate degree from Kansai Medical University.
Actieve functies van Minori Rosales
| Bedrijven | Functie | Begin |
|---|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-08-2026 |
Eerdere bekende functies van Minori Rosales
| Bedrijven | Functie | Einde |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-10-2025 |
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-05-2023 |
| MACROGENICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2022 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01-01-2018 |
Opleiding van Minori Rosales
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
32
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
SymBio Pharmaceuticals Ltd.
 SymBio Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutics for cancer and other related diseases | Health Technology |
Yamaguchi University
 Yamaguchi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Kansai Medical University
 Kansai Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compass Therapeutics, Inc.
 Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
